Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion-Reference-Cited by-同舟云学术

Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion

Published:2021-10 Issue:10 Volume:39 Page:1388-1403.e10
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Lan Yan,Moustafa Mahmoud^ORCID,Knoll Maximilian,Xu Chunxiao,Furkel Jennifer^ORCID,Lazorchak Adam,Yeung Tsz-Lun,Hasheminasab Sayed-Mohammad,Jenkins Molly H.^ORCID,Meister Sarah,Yu Huakui,Schlegel Julian^ORCID,Marelli Bo^ORCID,Tang Zili,Qin Guozhong,Klein Carmen^ORCID,Qi Jin,Zhou Cheng^ORCID,Locke George,Krunic Damir^ORCID,Derner Melissa G.^ORCID,Schwager Christian,Fontana Rachel E.,Kriegsmann Katharina^ORCID,Jiang Feng,Rein Katrin,Kriegsmann Mark^ORCID,Debus Juergen^ORCID,Lo Kin-Ming,Abdollahi Amir^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference47 articles.

1. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy;Abdollahi;Drug Resist. Updat.,2010

2. Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer;Antonia;N. Engl. J. Med.,2017

3. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence;Barker;Nat. Rev. Cancer,2015

4. Thalidomide (THD) alleviates radiation induced lung fibrosis (RILF) via down-regulation of TGF-beta/Smad3 signaling pathway in an Nrf2-dependent manner;Bian;Free Radic. Biol. Med.,2018

5. Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer;Cadranel;Eur. Respir. Rev.,2019

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arginine methylation and respiratory disease;Translational Research;2024-10

2. Galunisertib promotes bevacizumab-induced vascular normalization in nasopharyngeal carcinoma: Multi-parameter MRI evaluation;Molecular Therapy: Oncology;2024-09

3. Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy;Acta Pharmaceutica Sinica B;2024-09

4. Immunogenomic profiles and therapeutic options of the pan-programmed cell death-related lncRNA signature for patients with bladder cancer;Scientific Reports;2024-08-09

5. Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer;Nature Reviews Urology;2024-08-07